홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 94003생성일: 2026년 10월 27일

2-(벤조일록시메틸)벤조산

2-(벤조일록시메틸)벤조산 · Einecs 261-185-3 · 2-(benzyloxymethyl)benzoic acid · 2-(Benzoyloxymethyl)benzoic acid · Benzoic acid, 2-[(benzoyloxy)methyl]- · 2-(HYDROXYMETHYL)BENZOIC ACID BENZOATE

https://huagongshe.com/ko/chemical/94003

2-(벤조일록시메틸)벤조산 분자 구조식

식별자 및 물리적 특성

CAS No.58249-83-5
분자식C15H12O4
평균 분자량256.25 g/mol
단동위원소 질량256.07355886 g/mol
SMILESO=C(OCc1ccccc1C(=O)O)c1ccccc1
InChIKeyQDENBWUYSUBCID-UHFFFAOYSA-N
PubChem CID94003
EC No.261-185-3
DTXSIDDTXSID40973805
현지명2-(벤조일록시메틸)벤조산

화학 및 물리적 성질

XLogP2.8
극성 표면적63.6
수소 결합 공여자 수1
수소 결합 수용자 수4
회전 가능 결합 수5
무거운 원자 수19
형식 전하0
복잡도320
녹는점126-129 °C
끓는 점425.0±20.0 °C(Predicted)
밀도1.277±0.06 g/cm3(Predicted)
pKa(산도 계수)3.74±0.36(Predicted)
BRN2131052
주요 응용펩타이드 합성
InChI1S/C15H12O4/c16-14(17)13-9-5-4-8-12(13)10-19-15(18)11-6-2-1-3-7-11/h1-9H,10H2,(H,16,17)
InChIKeyQDENBWUYSUBCID-UHFFFAOYSA-N
SMILESOC(=O)c1ccccc1COC(=O)c2ccccc2

안전 및 규제

GHS 분류WarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesSkin Irrit. 2 (100%)
수질 위해 등급(WGK)3
위험 문구(R)36/37/38
위험 표시Xi
안전 문구(S)26-36
위험 등급Eye Irrit. 2Skin Irrit. 2STOT SE 3
저장 분류11 - Combustible Solids

용도

용도

2-(Benzoyloxymethyl)benzoic acid can be used to synthesize: 2-(Benzoyloxymethyl)benzoyl chloride (BMBC) by reacting with oxalyl chloride. BMBC intermediate is utilized for the preparation of dimethyl 2-(benzoyloxymethyl)benzoylphosphonate by treating with trimethyl phosphite. 2-Benzoyloxymethylbenzoic acid 4-nitrophenyl ester by reaction with 4-nitrophenol via 2-benzoyloxymethylbenzoyl chloride formation. 2-[2-(Benzoyloxymethyl)benzamido]acetamide by treating with glycinamide and followed by addition of PCl3.